Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

10

Number of overlapping holdings

41.7%

% of PPH's 27 holdings also in XLV

16.7%

% of XLV's 60 holdings also in PPH

Overlap by Weight
Sector Drift (PPH minus XLV)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PPH
Weight
in XLV
Overlap
ELI LILLY & CO 11.9% 12.3% 11.9%
JOHNSON & JOHNSON 6.6% 7.5% 6.6%
ABBVIE INC 6.5% 6.9% 6.5%
MERCK & CO. INC. 4.8% 4.3% 4.3%
PFIZER INC 4.4% 2.7% 2.7%

Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XLV
NOVARTIS AG-ADR 5.2%
ASTRAZENECA PLC-SPONS ADR 4.9%
SANOFI-AVENTIS-ADR 4.9%
NOVO-NORDISK A/S-SPONS ADR 4.7%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS 4.6%
GLAXOSMITHKLINE PLC-SPON ADR 4.5%
TEVA PHARMACEUTICAL-SP ADR 4.1%
CENCORA INC 4.0%
ZOETIS INC 3.2%
MCKESSON CORP 3.1%
PPH Underweight Relative to XLV
UNITEDHEALTH GROUP INC -9.0%
ABBOTT LABORATORIES -4.3%
THERMO FISHER SCIENTIFIC INC -3.6%
INTUITIVE SURGICAL INC -3.3%
AMGEN INC -3.1%
BOSTON SCIENTIFIC CORP -2.8%
GILEAD SCIENCES INC -2.6%
DANAHER CORP -2.5%
VERTEX PHARMACEUTICALS INC -2.4%
STRYKER CORP -2.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY